1. Home
  2. ATHE vs HUDI Comparison

ATHE vs HUDI Comparison

Compare ATHE & HUDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHE
  • HUDI
  • Stock Information
  • Founded
  • ATHE 1997
  • HUDI 2018
  • Country
  • ATHE Australia
  • HUDI China
  • Employees
  • ATHE N/A
  • HUDI N/A
  • Industry
  • ATHE Biotechnology: Pharmaceutical Preparations
  • HUDI Steel/Iron Ore
  • Sector
  • ATHE Health Care
  • HUDI Industrials
  • Exchange
  • ATHE Nasdaq
  • HUDI Nasdaq
  • Market Cap
  • ATHE 21.4M
  • HUDI 23.2M
  • IPO Year
  • ATHE N/A
  • HUDI 2021
  • Fundamental
  • Price
  • ATHE $4.75
  • HUDI $1.56
  • Analyst Decision
  • ATHE Strong Buy
  • HUDI
  • Analyst Count
  • ATHE 2
  • HUDI 0
  • Target Price
  • ATHE $8.00
  • HUDI N/A
  • AVG Volume (30 Days)
  • ATHE 1.3M
  • HUDI 15.6K
  • Earning Date
  • ATHE 02-15-2025
  • HUDI 02-14-2025
  • Dividend Yield
  • ATHE N/A
  • HUDI N/A
  • EPS Growth
  • ATHE N/A
  • HUDI N/A
  • EPS
  • ATHE N/A
  • HUDI 0.01
  • Revenue
  • ATHE $2,681,669.00
  • HUDI $74,270,429.00
  • Revenue This Year
  • ATHE N/A
  • HUDI N/A
  • Revenue Next Year
  • ATHE N/A
  • HUDI N/A
  • P/E Ratio
  • ATHE N/A
  • HUDI $155.75
  • Revenue Growth
  • ATHE 2.63
  • HUDI N/A
  • 52 Week Low
  • ATHE $1.00
  • HUDI $1.47
  • 52 Week High
  • ATHE $5.87
  • HUDI $4.25
  • Technical
  • Relative Strength Index (RSI)
  • ATHE 75.45
  • HUDI 31.96
  • Support Level
  • ATHE $2.76
  • HUDI $1.52
  • Resistance Level
  • ATHE $5.14
  • HUDI $1.60
  • Average True Range (ATR)
  • ATHE 0.42
  • HUDI 0.07
  • MACD
  • ATHE 0.15
  • HUDI -0.01
  • Stochastic Oscillator
  • ATHE 71.14
  • HUDI 0.00

About ATHE Alterity Therapeutics Limited

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Products are exported to the United States, Mexico, Thailand, Australia, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

Share on Social Networks: